Smoothing the Path to Pharma 4.0: Challenges and Solutions
Publication
Article
BioPharm InternationalBioPharm International, Manufacturing and Facilities November 2022
Volume 2022 eBook
Issue 4
Pages: 8-11
By taking a digital maturity-first approach to Pharma 4.0, manufacturers can optimally position themselves for success.
knssr - Stock.adobe.com
As pharmaceutical manufacturing grows in pace and complexity, companies are increasingly looking to Pharma 4.0 as a solution, with its promise of simplified workflows, shortened timelines, and more cost-effective routes to market. But while Pharma 4.0 offers many opportunities, the route to achieving Pharma 4.0 is challenging. Prioritizing the wrong technologies early in the transformation process can have severe and long-lasting impacts, and at every step of the journey pharmaceutical companies are faced with stumbling blocks that can halt progress.
Read this article in the Manufacturing and Facilities 2022 eBook
About the authors
Nicola Gardner is senior product marketing manager at Thermo Fisher Scientific.
Article details
BioPharm International
eBook: Manufacturing and Facilities 2022
November 2022
Pages: 8-11
Citation
When referring to this article, please cite it as N. Gardner, “Smoothing the Path to Pharma 4.0: Challenges and Solutions,” BioPharm International, Manufacturing and Facilities eBook 2022 (November 2022).
Recent Videos
